BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8417533)

  • 1. Reversible obstructive hypertrophic cardiomyopathy after dexamethasone therapy for bronchopulmonary dysplasia.
    Ohning BL; Fyfe DA; Riedel PA
    Am Heart J; 1993 Jan; 125(1):253-6. PubMed ID: 8417533
    [No Abstract]   [Full Text] [Related]  

  • 2. [Transient hypertrophic cardiomyopathy due to dexamethasone therapy in a premature infant].
    Pokela ML
    Duodecim; 1995; 111(14):1310-3. PubMed ID: 9244681
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversible steroid-induced hypertrophic cardiomyopathy with left ventricular outflow tract obstruction in two newborns.
    Haney I; Lachance C; van Doesburg NH; Fouron JC
    Am J Perinatol; 1995 Jul; 12(4):271-4. PubMed ID: 7575834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertrophic cardiomyopathy in preterm infants treated with methylprednisolone for bronchopulmonary dysplasia.
    Dani C; Bertini G; Simone P; Rubaltelli FF
    Pediatrics; 2006 May; 117(5):1866-7. PubMed ID: 16651362
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypertrophic obstructive cardiomyopathy as a side effect of dexamethasone treatment for bronchopulmonary dysplasia.
    Brand PL; van Lingen RA; Brus F; Talsma MD; Elzenga NJ
    Acta Paediatr; 1993; 82(6-7):614-7. PubMed ID: 8339005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertrophic cardiomyopathy in a low-birth-weight newborn treated with dexamethasone].
    Villa Alcázar M; Pellicer Martínez A; Burgueros Valero M; Quero Jiménez J
    An Esp Pediatr; 1996 Apr; 44(4):393-4. PubMed ID: 8796947
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosuppressive drugs and hypertrophic cardiomyopathy.
    Brand PL; Brus F
    Lancet; 1995 Jun; 345(8965):1644. PubMed ID: 7540240
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia.
    Werner JC; Sicard RE; Hansen TW; Solomon E; Cowett RM; Oh W
    J Pediatr; 1992 Feb; 120(2 Pt 1):286-91. PubMed ID: 1735831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of beta-blockade on symptomatic dexamethasone-induced hypertrophic obstructive cardiomyopathy in premature infants: three case reports and literature review.
    Fritz KI; Bhat AM
    J Perinatol; 1998; 18(1):38-44. PubMed ID: 9527943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone given to premature infants and cardiac diastolic function in early childhood.
    Wong IH; Digby AM; Warren AE; Pepelassis D; Vincer M; Chen RP
    J Pediatr; 2011 Aug; 159(2):227-31. PubMed ID: 21397911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glucocorticoid-induced hypertrophic cardiomyopathy in premature infants: apropos of 4 cases].
    Boeuf B; Maragnes P; Belzic I; Lacotte J; Bonte JB; Guillois B
    Arch Pediatr; 1997 Feb; 4(2):152-7. PubMed ID: 9097827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertrophic Cardiomyopathy After a Single Dose of Dexamethasone in a Preterm Infant.
    Kale Y; Aydemir O; Ceylan O; Bas AY; Demirel N
    Pediatr Neonatol; 2015 Aug; 56(4):268-70. PubMed ID: 23639746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular and metabolic side effects associated with hydrocortisone and dexamethasone use in VLBW infants: a single-centre experience.
    Röhr SB; Sauer H; Gortner L; Gräber S; Meyer S
    Acta Paediatr; 2013 Oct; 102(10):e436. PubMed ID: 23819647
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypertrophic intraventricular flow obstruction after very-low-dose dexamethasone (Minidex) in preterm infants: case presentation and review of the literature.
    Paech C; Wolf N; Thome UH; Knüpfer M
    J Perinatol; 2014 Mar; 34(3):244-6. PubMed ID: 24573211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Secondary myocardial hypertrophy in a very small premature infant treated with dexamethasone].
    Korsch E; Gillor A; Groneck P; Bläker F
    Monatsschr Kinderheilkd; 1993 Feb; 141(2):112-5. PubMed ID: 8459811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Policy statement--postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia.
    Watterberg KL;
    Pediatrics; 2010 Oct; 126(4):800-8. PubMed ID: 20819899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertrophic cardiomyopathy in preterm infants treated with dexamethasone.
    Miranda-Mallea J; Pérez-Verdú J; Gascó-Lacalle B; Sáez-Palacios JM; Fernández-Gilino C; Izquierdo-Macián I
    Eur J Pediatr; 1997 May; 156(5):394-6. PubMed ID: 9177985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia.
    Williams AF
    Arch Dis Child; 1993 Sep; 69(3 Spec No):331. PubMed ID: 8215580
    [No Abstract]   [Full Text] [Related]  

  • 19. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia.
    Ng PC
    Arch Dis Child; 1993 Mar; 68(3 Spec No):330-6. PubMed ID: 8466274
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of dexamethasone in premature infants at risk for bronchopulmonary dysplasia or who already have developed chronic lung disease: a cautionary note.
    Frank L
    Pediatrics; 1991 Aug; 88(2):413-6. PubMed ID: 1741827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.